메뉴 건너뛰기




Volumn 28, Issue SUPP. 3, 2008, Pages

Icodextrin and intraperitoneal inflammation

Author keywords

Icodextrin peritoneal dialysis fluid; Peritoneal inflammation; Peritoneal permeability

Indexed keywords

ALPHA 2 MACROGLOBULIN; BETA 2 MICROGLOBULIN; FIBRINOGEN DEGRADATION PRODUCT; GLUCOSE; ICODEXTRIN; INTERLEUKIN 6; PERITONEAL DIALYSIS FLUID; PREDNISOLONE;

EID: 48749100219     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (32)

References (17)
  • 1
    • 0344874202 scopus 로고    scopus 로고
    • Willams JD, Craig KJ, von Ruhland C, Topley N, Willams GT on behalf of the Biopsy Registry Study Group. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; 88:S43-9.
    • Willams JD, Craig KJ, von Ruhland C, Topley N, Willams GT on behalf of the Biopsy Registry Study Group. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; 88:S43-9.
  • 3
    • 1442286318 scopus 로고    scopus 로고
    • Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions
    • Parikova A, Zweers MM, Struijk DG, Krediet RT. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Adv Perit Dial 2003; 19:186-90.
    • (2003) Adv Perit Dial , vol.19 , pp. 186-190
    • Parikova, A.1    Zweers, M.M.2    Struijk, D.G.3    Krediet, R.T.4
  • 4
    • 34547176159 scopus 로고    scopus 로고
    • 2-microglobulin and peritoneal injury markers in 7.5% icodextrin-based peritoneal dialysis solution
    • 2-microglobulin and peritoneal injury markers in 7.5% icodextrin-based peritoneal dialysis solution. Ther Apher Dial 2007; 11:296-300.
    • (2007) Ther Apher Dial , vol.11 , pp. 296-300
    • Minami, S.1    Hora, K.2    Kamijo, Y.3    Higuchi, M.4
  • 5
    • 26844540903 scopus 로고    scopus 로고
    • Glucose-free dialysis solutions: Inductors of inflammation or preservers of peritoneal membrane?
    • Martikainen TA, Teppo AM, Grönhagen-Riska C, Ekstrand AV. Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane? Perit Dial Int 2005; 25:453-60.
    • (2005) Perit Dial Int , vol.25 , pp. 453-460
    • Martikainen, T.A.1    Teppo, A.M.2    Grönhagen-Riska, C.3    Ekstrand, A.V.4
  • 6
    • 0036377004 scopus 로고    scopus 로고
    • Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin
    • Gotloib L, Wajsbrot V, Shostak A. Mesothelial dysplastic changes and lipid peroxidation induced by 7.5% icodextrin. Nephron 2002; 92:142-55.
    • (2002) Nephron , vol.92 , pp. 142-155
    • Gotloib, L.1    Wajsbrot, V.2    Shostak, A.3
  • 7
    • 0035126233 scopus 로고    scopus 로고
    • Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation
    • Ha H, Yu MR, Choi HN, Cha MK, Kang HS, Kim MH, et al. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation. Perit Dial Int 2000; 20(Suppl 5):S10-18.
    • (2000) Perit Dial Int , vol.20 , Issue.SUPPL. 5
    • Ha, H.1    Yu, M.R.2    Choi, H.N.3    Cha, M.K.4    Kang, H.S.5    Kim, M.H.6
  • 8
    • 0002070588 scopus 로고
    • History, chemical, and pharmaceutical development of icodextrin
    • Alsop RM. History, chemical, and pharmaceutical development of icodextrin. Perit Dial Int 1994; 14:S5-12.
    • (1994) Perit Dial Int , vol.14
    • Alsop, R.M.1
  • 9
    • 13844253693 scopus 로고    scopus 로고
    • Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution
    • Martis L, Patel M, Giertych J, Mongoven J, Taminne M, Perrier MA, et al. Aseptic peritonitis due to peptidoglycan contamination of pharmacopoeia standard dialysis solution. Lancet 2005; 365:588-94.
    • (2005) Lancet , vol.365 , pp. 588-594
    • Martis, L.1    Patel, M.2    Giertych, J.3    Mongoven, J.4    Taminne, M.5    Perrier, M.A.6
  • 10
    • 0142150129 scopus 로고    scopus 로고
    • Exposure to the peptidoglycan contaminantin icodextrin may cause sensitization of the patient maintained on peritoneal dialysis
    • Povlsen JV, Ivarsen P, Jørgensen KA, Madsen S. Exposure to the peptidoglycan contaminantin icodextrin may cause sensitization of the patient maintained on peritoneal dialysis. Perit Dial Int 2003; 23:509-10.
    • (2003) Perit Dial Int , vol.23 , pp. 509-510
    • Povlsen, J.V.1    Ivarsen, P.2    Jørgensen, K.A.3    Madsen, S.4
  • 11
    • 1642561679 scopus 로고    scopus 로고
    • Icodextrin-induced peritonitis: Study of five cases and comparison with bacterial peritonitis
    • Touré F, Lavaud S, Mohajer M, Lavaud F, Canivet E, Nguyen P, et al. Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis. Kidney Int 2004; 65:654-60.
    • (2004) Kidney Int , vol.65 , pp. 654-660
    • Touré, F.1    Lavaud, S.2    Mohajer, M.3    Lavaud, F.4    Canivet, E.5    Nguyen, P.6
  • 12
    • 20144387725 scopus 로고    scopus 로고
    • Longitudinal membrane function in functionally anuric patients treated with APD: Data from EAPOS on the effects of glucose and icodextrin prescription
    • Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil A, et al. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 2005; 67:1609-15.
    • (2005) Kidney Int , vol.67 , pp. 1609-1615
    • Davies, S.J.1    Brown, E.A.2    Frandsen, N.E.3    Rodrigues, A.S.4    Rodriguez-Carmona, A.5    Vychytil, A.6
  • 13
    • 0035117195 scopus 로고    scopus 로고
    • Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo
    • Baio MA, Selgas R, Castro MA, del Peso G, Diaz C, Sánchez-Tomero JA, et al. Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo. Perit Dial Int 2000; 20:742-7.
    • (2000) Perit Dial Int , vol.20 , pp. 742-747
    • Baio, M.A.1    Selgas, R.2    Castro, M.A.3    del Peso, G.4    Diaz, C.5    Sánchez-Tomero, J.A.6
  • 14
    • 30944445781 scopus 로고    scopus 로고
    • Influence of icodextrin on plasma and diatysate levels of Nε-(carboxymethyl)lysine and Nε-(carboxyethyl)lysine
    • Konings CJ, Schalkwijk CG, van der Sande FM, Leunissen KM, Kooman JP. Influence of icodextrin on plasma and diatysate levels of Nε-(carboxymethyl)lysine and Nε-(carboxyethyl)lysine. Perit Dial Int 2005; 25:591-5.
    • (2005) Perit Dial Int , vol.25 , pp. 591-595
    • Konings, C.J.1    Schalkwijk, C.G.2    van der Sande, F.M.3    Leunissen, K.M.4    Kooman, J.P.5
  • 15
    • 33745505947 scopus 로고    scopus 로고
    • Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane
    • Moriishi M, Kawanishi H, Watanabe H, Tsuchiya S. Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane. Adv Perit Dial 2005; 21:21-4.
    • (2005) Adv Perit Dial , vol.21 , pp. 21-24
    • Moriishi, M.1    Kawanishi, H.2    Watanabe, H.3    Tsuchiya, S.4
  • 16
    • 7044220462 scopus 로고    scopus 로고
    • Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution
    • Moriishi M, Kawanishi H, Watanabe H, Tsuchiya S. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution. Adv Perit Dial 2004; 20:166-9.
    • (2004) Adv Perit Dial , vol.20 , pp. 166-169
    • Moriishi, M.1    Kawanishi, H.2    Watanabe, H.3    Tsuchiya, S.4
  • 17
    • 33846371560 scopus 로고    scopus 로고
    • Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients
    • Moriishi M, Kawanishi H, Tsuchiya S. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients. Adv Perit Dial 2006; 22:24-8.
    • (2006) Adv Perit Dial , vol.22 , pp. 24-28
    • Moriishi, M.1    Kawanishi, H.2    Tsuchiya, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.